Abstract
Oxidative stress is an important agent of systemic damage caused by hyperglycemia in diabetes. Experimental studies have shown that the neurohormone melatonin, due to its antioxidant properties, can combat oxidative stress in diabetes. However, most experimental studies use highly concentrated doses of this hormone and only evaluate its effects after the induction of diabetes, regardless …